Every year ASCO publishes its State of Cancer Care report, which details many of the challenges and opportunities facing oncology practices, payers, and patients. We highlight stakeholder perspectives while taking an in-depth look at this year's repo...
The annual AACR meeting was full of surprises this year: a new drug for a type of cancer that until now had no approved treatments, a study that investigated how gut bacteria influences patients' response to anti-PD-1 agents, and an unusual skull cap...
From this year's ACCC annual meeting in Washington DC, themed Cancerscape, we cover the market forces affecting cancer programs, the application of value-based frameworks, and drug pricing under the Trump administration....